Does the dark genome hold the key to the treatment of schizophrenia and bipolar?
In 10 seconds? A recent study suggests that the origins of schizophrenia and bipolar disorder may lie in elements of our “dark genome” and that products originating from here could be novel drug targets and/or help identify people...